» Articles » PMID: 24719890

Hepatitis B Virus X Upregulates HuR Protein Level to Stabilize HER2 Expression in Hepatocellular Carcinoma Cells

Abstract

Hepatitis B virus- (HBV-) associated hepatocellular carcinoma (HCC) is the most common type of liver cancer. However, the underlying mechanism of HCC tumorigenesis is very complicated and HBV-encoded X protein (HBx) has been reported to play the most important role in this process. Activation of downstream signal pathways of epidermal growth factor receptor (EGFR) family is known to mediate HBx-dependent HCC tumor progression. Interestingly, HER2 (also known as ErbB2/Neu/EGFR2) is frequently overexpressed in HBx-expressing HCC patients and is associated with their poor prognosis. However, it remains unclear whether and how HBx regulates HER2 expression. In this study, our data showed that HBx expression increased HER2 protein level via enhancing its mRNA stability. The induction of RNA-binding protein HuR expression by HBx mediated the HER2 mRNA stabilization. Finally, the upregulated HER2 expression promoted the migration ability of HBx-expressing HCC cells. These findings deciphered the molecular mechanism of HBx-mediated HER2 upregulation in HBV-associated HCC.

Citing Articles

Mechanisms and therapeutic targets of ErbB family receptors in hepatocellular carcinoma: a narrative review.

Qiang Z, Wan J, Chen X, Wang H Transl Cancer Res. 2024; 13(6):3156-3178.

PMID: 38988928 PMC: 11231811. DOI: 10.21037/tcr-24-837.


Exosomal Linc00969 induces trastuzumab resistance in breast cancer by increasing HER-2 protein expression and mRNA stability by binding to HUR.

Liu C, Lu C, Yixi L, Hong J, Dong F, Ruan S Breast Cancer Res. 2023; 25(1):124.

PMID: 37848981 PMC: 10580635. DOI: 10.1186/s13058-023-01720-6.


Prognostic Value of Erythroblastic Leukemia Viral Oncogene Homolog 2 and Neuregulin 4 in Hepatocellular Carcinoma.

Rou W, Eun H, Choung S, Jeon H, Joo J, Kang S Cancers (Basel). 2023; 15(9).

PMID: 37174100 PMC: 10177431. DOI: 10.3390/cancers15092634.


Human Epidermal Growth Factor Receptor 2 (HER2) Expression by Immunohistochemistry and Its Clinical Significance in Hepatocellular Carcinoma: A Single-Center Analysis.

Magalhaes D, Dos Santos J, Frutuoso A, Mesquita A Cureus. 2023; 15(2):e34724.

PMID: 36909127 PMC: 9997104. DOI: 10.7759/cureus.34724.


Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.

Ahluwalia S, Ahmad B, Salim U, Ghosh D, Kamuju V, Ghosh A Microbiol Spectr. 2022; 10(5):e0273121.

PMID: 35993712 PMC: 9603668. DOI: 10.1128/spectrum.02731-21.


References
1.
Wu C, Yen C, Chou R, Chen J, Huang W, Wu C . Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression. Int J Cancer. 2013; 134(7):1638-47. DOI: 10.1002/ijc.28501. View

2.
Marmor M, Skaria K, Yarden Y . Signal transduction and oncogenesis by ErbB/HER receptors. Int J Radiat Oncol Biol Phys. 2004; 58(3):903-13. DOI: 10.1016/j.ijrobp.2003.06.002. View

3.
Liu J, Ahiekpor A, Li L, Li X, Arbuthnot P, Kew M . Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer. Int J Cancer. 2009; 125(8):1894-901. PMC: 2745322. DOI: 10.1002/ijc.24580. View

4.
Matsui K, Sugimori K, Motomura H, Ejiri N, Tsukada K, Kitajima I . PEA3 cooperates with c-Jun in regulation of HER2/neu transcription. Oncol Rep. 2006; 16(1):153-8. View

5.
Gotte M . MicroRNAs in breast cancer pathogenesis. Minerva Ginecol. 2010; 62(6):559-71. View